🚀 VC round data is live in beta, check it out!
SC Ropharma Valuation Multiples
Discover revenue and EBITDA valuation multiples for SC Ropharma and similar public comparables like Farmacosmo, Pilulka Lekarny, Wellgistics Health, Talea Group and more.
SC Ropharma Overview
About SC Ropharma
SC Ropharma SA is engaged in the production, distribution, and Retail sale of pharmaceutical products in specialized stores. Its product portfolio comprises over 50 products in the form of tablets, powders, capsules, and syrups covering 21 therapeutic areas.
Founded
1952
HQ
Employees
1.3K
Website
Sectors
Financials (FY)
EV
$57M
SC Ropharma Financials
SC Ropharma reported last fiscal year revenue of $273M and EBITDA of $13M.
In the same fiscal year, SC Ropharma generated $38M in gross profit, $13M in EBITDA, and had net loss of ($395K).
SC Ropharma P&L
In the most recent fiscal year, SC Ropharma reported revenue of $273M and EBITDA of $13M.
SC Ropharma expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $273M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $38M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 14% | XXX | XXX | XXX |
| EBITDA | — | XXX | $13M | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 5% | XXX | XXX | XXX |
| EBIT Margin | — | XXX | 2% | XXX | XXX | XXX |
| Net Profit | — | XXX | ($395K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (0%) | XXX | XXX | XXX |
| Net Debt | — | — | $11M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
SC Ropharma Stock Performance
SC Ropharma has current market cap of $24M, and enterprise value of $57M.
Market Cap Evolution
SC Ropharma's stock price is $0.05.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $57M | $24M | 1.7% | XXX | XXX | XXX | $-0.00 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialSC Ropharma Valuation Multiples
SC Ropharma trades at 0.2x EV/Revenue multiple, and 4.4x EV/EBITDA.
SC Ropharma Financial Valuation Multiples
As of April 11, 2026, SC Ropharma has market cap of $24M and EV of $57M.
Equity research analysts estimate SC Ropharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
SC Ropharma has a P/E ratio of (60.4x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $24M | XXX | $24M | XXX | XXX | XXX |
| EV (current) | $57M | XXX | $57M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 0.2x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | 4.4x | XXX | XXX | XXX |
| EV/EBIT | — | XXX | 8.9x | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 1.5x | XXX | XXX | XXX |
| P/E | — | XXX | (60.4x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | 10.1x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified SC Ropharma Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
SC Ropharma Margins & Growth Rates
SC Ropharma's revenue in the last fiscal year grew by 18%.
SC Ropharma's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.0M for the same period.
SC Ropharma Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 18% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | 5% | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 0% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 12% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
SC Ropharma Public Comps
See public comps and valuation multiples for other Pharmacies comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Farmacosmo | XXX | XXX | XXX | XXX | XXX | XXX |
| Pilulka Lekarny | XXX | XXX | XXX | XXX | XXX | XXX |
| Wellgistics Health | XXX | XXX | XXX | XXX | XXX | XXX |
| Talea Group | XXX | XXX | XXX | XXX | XXX | XXX |
| PetMeds | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
SC Ropharma M&A Activity
SC Ropharma acquired XXX companies to date.
Last acquisition by SC Ropharma was on XXXXXXXX, XXXXX. SC Ropharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by SC Ropharma
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialSC Ropharma Investment Activity
SC Ropharma invested in XXX companies to date.
SC Ropharma made its latest investment on XXXXXXXX, XXXXX. SC Ropharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by SC Ropharma
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout SC Ropharma
| When was SC Ropharma founded? | SC Ropharma was founded in 1952. |
| Where is SC Ropharma headquartered? | SC Ropharma is headquartered in Romania. |
| How many employees does SC Ropharma have? | As of today, SC Ropharma has over 1K employees. |
| Is SC Ropharma publicly listed? | Yes, SC Ropharma is a public company listed on Bucharest Stock Exchange. |
| What is the stock symbol of SC Ropharma? | SC Ropharma trades under RPH ticker. |
| When did SC Ropharma go public? | SC Ropharma went public in 1997. |
| Who are competitors of SC Ropharma? | SC Ropharma main competitors are Farmacosmo, Pilulka Lekarny, Wellgistics Health, Talea Group. |
| What is the current market cap of SC Ropharma? | SC Ropharma's current market cap is $24M. |
| What is the current revenue of SC Ropharma? | SC Ropharma's last fiscal year revenue is $273M. |
| What is the current EV/Revenue multiple of SC Ropharma? | Current revenue multiple of SC Ropharma is 0.2x. |
| Is SC Ropharma profitable? | No, SC Ropharma is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.